SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Section 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of March 2020
Commission File Number: 001-39034
BELLUS HEALTH INC.
(Name of registrant)
275 Armand-Frappier Blvd.
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F [ ] Form 40-F [ X ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1). ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|Dated: March 11, 2020||BELLUS Health Inc..|
|By:||/s/ François Desjardins|
|Title:||Vice President, Finance|
|99.1||Notice of the Meeting and Record Date|
|1500 Robert-Bourassa Blvd.|
|Date: March 11, 2020||7th Floor|
|Montreal QC, H3A 3S8|
|To:||All Canadian Securities Regulatory Authorities|
Subject: BELLUS HEALTH INC.
We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:
|Meeting Type :||Annual General and Special Meeting|
|Record Date for Notice of Meeting :||March 27, 2020|
|Record Date for Voting (if applicable) :||March 27, 2020|
|Beneficial Ownership Determination Date :||March 27, 2020|
|Meeting Date :||May 14, 2020|
|Meeting Location (if available) :||Laval, QC|
|Issuer sending proxy related materials directly to NOBO:||Yes|
|Issuer paying for delivery to OBO:||Yes|
|Notice and Access (NAA) Requirements:|
NAA for Beneficial Holders
NAA for Registered Holders
|Voting Security Details:|
Agent for BELLUS HEALTH INC.